Literature DB >> 11906992

Rapamycin eluting stent: the onset of a new era in interventional cardiology.

P W Serruys, E Regar, A J Carter.   

Abstract

Mesh：

Substances：

Year:  2002        PMID： 11906992      PMCID： PMC1767071          DOI： 10.1136/heart.87.4.305

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  10 in total

1.  Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells.

Authors:  S O Marx; T Jayaraman; L O Go; A R Marks
Journal:  Circ Res       Date:  1995-03       Impact factor: 17.367

2.  Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: Detection of FK506-binding protein 12 upregulation.

Authors:  D Zohlnhöfer; C A Klein; T Richter; R Brandl; A Murr; T Nührenberg; A Schömig; P A Baeuerle; F J Neumann
Journal:  Circulation       Date:  2001-03-13       Impact factor: 29.690

3.  Different inhibitory effects of immunosuppressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell growth factor.

Authors:  P J Mohacsi; D Tüller; B Hulliger; P L Wijngaard
Journal:  J Heart Lung Transplant       Date:  1997-05       Impact factor: 10.247

4.  Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study.

Authors:  J E Sousa; M A Costa; A Abizaid; A S Abizaid; F Feres; I M Pinto; A C Seixas; R Staico; L A Mattos; A G Sousa; R Falotico; J Jaeger; J J Popma; P W Serruys
Journal:  Circulation       Date:  2001-01-16       Impact factor: 29.690

5.  Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.

Authors:  B J Rensing; J Vos; P C Smits; D P Foley; M J van den Brand; W J van der Giessen; P J de Feijter; P W Serruys
Journal:  Eur Heart J       Date:  2001-11       Impact factor: 29.983

6.  Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.

Authors:  R Gallo; A Padurean; T Jayaraman; S Marx; M Roque; S Adelman; J Chesebro; J Fallon; V Fuster; A Marks; J J Badimon
Journal:  Circulation       Date:  1999-04-27       Impact factor: 29.690

7.  Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model.

Authors:  T Suzuki; G Kopia; S Hayashi ; L R Bailey; G Llanos; R Wilensky; B D Klugherz; G Papandreou; P Narayan; M B Leon; A C Yeung; F Tio; P S Tsao; R Falotico; A J Carter
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

8.  Rapamycin inhibits vascular smooth muscle cell migration.

Authors:  M Poon; S O Marx; R Gallo; J J Badimon; M B Taubman; A R Marks
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

9.  Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.

Authors:  C R Gregory; X Huang; R E Pratt; V J Dzau; R Shorthouse; M E Billingham; R E Morris
Journal:  Transplantation       Date:  1995-03-15       Impact factor: 4.939

10.  Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels.

Authors:  C R Gregory; P Huie; M E Billingham; R E Morris
Journal:  Transplantation       Date:  1993-06       Impact factor: 4.939
  10 in total
  19 in total

1.  Endovascular stent implantation for isolated pulmonary arterial stenosis caused by Takayasu's arteritis.

Authors:  De Li; Shuangtao Ma; Gang Li; Jinsong Chen; Bing Tang; Xin Zhang; Dachun Yang; Yongjian Yang
Journal:  Clin Res Cardiol       Date:  2010-04-20       Impact factor: 5.460

2.  Health economic evaluation of the use of drug-eluting stents : First results from the Drug-Eluting Stent Registry (DES.de).

Authors:  S N Willich; F Müller-Riemenschneider; D McBride; S Silber; K-H Kuck; C A Nienaber; S Schneider; J Senges; B Brüggenjürgen
Journal:  Herz       Date:  2012-02-02       Impact factor: 1.443

3.  Corrosion resistance studies on grain-boundary etched drug-eluting stents.

Authors:  Ralf Rettig; Julia Kunze; Michael Stöver; Erich Wintermantel; Sannakaisa Virtanen
Journal:  J Mater Sci Mater Med       Date:  2007-02-03       Impact factor: 3.896

Review 4.  The DESolve novolimus bioresorbable Scaffold: from bench to bedside.

Authors:  Alessio Mattesini; Simone Bartolini; Carlotta Sorini Dini; Serafina Valente; Guido Parodi; Miroslava Stolcova; Francesco Meucci; Carlo Di Mario
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

Review 5.  Biocompatible Polymer Materials with Antimicrobial Properties for Preparation of Stents.

Authors:  Kateřina Škrlová; Kateřina Malachová; Alexandra Muñoz-Bonilla; Dagmar Měřinská; Zuzana Rybková; Marta Fernández-García; Daniela Plachá
Journal:  Nanomaterials (Basel)       Date:  2019-10-31       Impact factor: 5.076

6.  Improving data quality and preserving HCD-generated reporter ions with EThcD for isobaric tag-based quantitative proteomics and proteome-wide PTM studies.

Authors:  Qing Yu; Xudong Shi; Yu Feng; K Craig Kent; Lingjun Li
Journal:  Anal Chim Acta       Date:  2017-03-16       Impact factor: 6.558

Review 7.  Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?

Authors:  Allen J Weiss; Marta Lorente-Ros; Ashish Correa; Nitin Barman; Jacqueline E Tamis-Holland
Journal:  Curr Atheroscler Rep       Date:  2022-07-11       Impact factor: 5.967

8.  Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury.

Authors:  Tillmann Cyrus; Huiying Zhang; John S Allen; Todd A Williams; Grace Hu; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-21       Impact factor: 8.311

Review 9.  Potential therapeutic effects of mTOR inhibition in atherosclerosis.

Authors:  Ammar Kurdi; Guido R Y De Meyer; Wim Martinet
Journal:  Br J Clin Pharmacol       Date:  2015-12-29       Impact factor: 4.335

Review 10.  Analysis of arterial intimal hyperplasia: review and hypothesis.

Authors:  Vladimir M Subbotin
Journal:  Theor Biol Med Model       Date:  2007-10-31       Impact factor: 2.432
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.